Point72 Asset Management
ORGO icon

Point72 Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Point72 Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-148,358
Closed -$352K – 4440
2026
Q1 		$352K Sell
148,358
-240,888
-62% -$834K ﹤0.01% 3302
2025
Q4 		$2.02M Buy
+389,246
New +$1.89M ﹤0.01% 2471
2023
Q4 		– Sell
-425,000
Closed -$1.35M – 2642
2023
Q3 		$1.35M Buy
425,000
+419,096
+7,099% +$1.33M ﹤0.01% 1240
2023
Q2 		$19.6K Sell
5,904
-62,427
-91% -$184K ﹤0.01% 1789
2023
Q1 		$146K Buy
+68,331
New +$169K ﹤0.01% 1561

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Point72 Asset Management's ORGO Position: Q2 2026 in Review

Point72 Asset Management sold out of Organogenesis Holdings (ORGO) in Q2 2026, closing a stake of 148,358 shares — an estimated $352K sold.

Point72 Asset Management first reported a position in ORGO in Q1 2023 and held it in 5 quarters. The position peaked at $2.02M in Q4 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Point72 Asset Management reported no remaining Organogenesis Holdings position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 148,358 Organogenesis Holdings shares in Q2 2026, an estimated $352K.
  • Point72 Asset Management first reported a position in Organogenesis Holdings in Q1 2023 and held it in 5 quarters.
  • Point72 Asset Management's Organogenesis Holdings position peaked at $2.02M in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.